The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
hepatitis uh B or C also increases your risk of hepatocellular cancer this is a bad actor this is a very bad cancer so part of the mortality here results not just from the reduction of synthetic function in the liver but from actual oncology
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the first is the risk of um liver failure and all of the things we talk about through this pathway of steatosis fibrosis and ultimately what is called curosis the irreversible fibrotic change of the liver but the other thing we have to talk about here is hepatocellular carcinoma which is a deadly type of cancer if not caught very very early